Conversely, IL‐6‐specific autoantibodies in systemic sclerosis have been suggested to stabilize IL‐6 in vivo as carriers, as its levels were higher in autoantibody positive patients than in negatives, and IL‐6 activity was found in the immune complexes 31. The gene discussed is IL6; the disease is systemic sclerosis.